№ files_lp_4_process_2_46359
Provides guidance on selecting and applying MedDRA terminology for consistent reporting of adverse events and clinical information in regulatory submissions.
Year: 2014
Region / Organization: International (ICH, EU, Japan, USA, Canada)
Subject: Regulatory terminology for medical products
Document type: Guidance document
Authority: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)
Authors: ICH Points to Consider Working Group, MedDRA Maintenance and Support Services Organization (MSSO), Japanese Maintenance Organization
Version: 4.7
Based on MedDRA Version: 17.0
Intended audience: MedDRA users in regulatory and industry settings
Date of release: March 2014
Content: Guidance on selection of MedDRA terms for reporting adverse events, diagnoses, and related clinical information
Scope: Covers term selection principles, use of medical judgment, and special cases including congenital conditions, neoplasms, medication errors, overdose, device-related terms, and off-label use
References: MedDRA browsing tools and related regulatory documentation
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.